NuvOx Pharma
Rong Wang is a highly experienced professional currently serving as the President and Chief Operating Officer at NuvOx Pharma. With a background in finance and operations, Rong has successfully led various companies through strategic acquisitions and has provided advisory services to multiple life science and technology organizations. Rong's expertise also includes serving in key roles at companies such as Tiempo Development, MID Labs Inc., and Abaxis. Rong holds an MBA from the University of Michigan's Ross School of Business, an MSE in Industrial Engineering from the University of Michigan, and a BS in Engineering from Tsinghua University.
This person is not in any teams
This person is not in any offices
NuvOx Pharma
NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ibready).